Mass Spec Matters
The annual ASMS show returned to the live stage this year, with plenty of new products and developments for an eager audience of mass spec enthusiasts
A promising display of new LC and GC products are indicative of the health of analytical industries and the economy as a whole. Here are a few notable new releases.
From virus detection to bloodborne pathogen screening, mass spec has proven invaluable for a wide variety of applications. Here we look at a few new compact and capable solutions, as well as the concepts these technologies are based upon.
2021 looks to be a year of significant growth and innovation in the HPLC and LC-MS fields. Here are a few early developments in the new year.
Several new FDA-approved tests based upon mass spectrometry showcase the power of mass spec, not only as a discovery technology, but as a capable platform for unprecedented public health challenges.
Mass spectrometry once again wields its might, combating the COVID-19 pandemic from multiple aspects. Here is a brief look at some of the method development and collaborative efforts that are leading the charge.
The purely digital “reboot” format for the conference this year made for an outstanding experience, rich with interactive, on-demand, and downloadable content -- in addition to some electrifying new product buzz.
Research into SARS-CoV-2 spike protein and other areas are contributing to the development of viable vaccines, drugs, and therapeutic antibodies -- all benefiting from new glycan analysis and LC-MS solutions.
New and emerging supercritical fluid chromatography applications have brought with them a host of new technologies -- with elevated performance, efficiency, and green chemistry as key drivers.
The new decade holds both promise and remaining challenges for widespread adoption of mass spectrometry in the clinical lab
Non-targeted, unlabeled, high-resolution spatial mapping – benchmarks of the new era of next-generation mass spectrometry imaging technologies.